Silva-Rojas R, Pérez-Guàrdia L, Simon A, Djeddi S, Treves S, Ribes A & al , ORAI1 inhibition as an efficient preclinical therapy for tubular aggregate myopathy and Stormorken syndrome., JCI Insight, 2024
Senff JR, Singh SD, Pasi M, Jolink WMT, Rodrigues MA, Schreuder FHBM & al , Long-Term Outcomes in Patients With Spontaneous Cerebellar Hemorrhage: An International Cohort Study., Stroke, 2024
Dujardin K, Tard C, Diglé E, Herlin V, Mutez E, Davion JB & al , Cognitive Impairment Is Part of the Phenotype of Cerebellar Ataxia, Neuropathy, Vestibular Areflexia Syndrome (CANVAS)., Mov Disord, 2024
Lopes R , Multifractal Analysis in Neuroimaging., Adv Neurobiol, 2024 , 79-93
Kamogawa N, Miwa K, Toyoda K, Jensen M, Inoue M, Yoshimura S & al , Thrombolysis for Wake-Up Stroke Versus Non-Wake-Up Unwitnessed Stroke: EOS Individual Patient Data Meta-Analysis., Stroke, 2024
Leys D, Sommer C, Borroni B, Chan A, Edwards M, Tessitore A & al , Lessons from the past to understand the future., Eur J Neurol, 2024 , e16270
Badinier J, Lopes R, Mastellari T, Fovet T, Williams SCR, Pruvo JP & al , Clinical and neuroimaging predictors of benzodiazepine response in catatonia: A machine learning approach., J Psychiatr Res, 2024 , 300-306
Schoser B, Kishnani PS, Bratkovic D, Byrne BJ, Claeys KG, Díaz-Manera J & al , 104-week efficacy and safety of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease: a phase III open-label extension study (ATB200-07)., J Neurol, 2024
Accettone T, Personnic T, Bretzner M, Behal H, Cordonnier C, Henon H & al , Impact of prodromal symptoms on the prognosis of patients with basilar artery occlusion treated with mechanical thrombectomy., Eur Stroke J, 2024 , 23969873241234844
Grzych G, Scuccimarra M, Plasse L, Gernez E, Cassim F, Touze B & al , Understanding Neuropathy Features in the Context of Nitrous Oxide Abuse: A Combined Electrophysiological and Metabolic Approach., Biomedicines, 2024
Wawrziczny E, Flinois B, Constant E, Brugallé E, Sokolowski C, Manceau C & al , Dealing with the diagnosis of Parkinson's disease and its implications for couple functioning in the early stage: An interpretative phenomenological analysis., PLoS One, 2024 , e0294240
Agbonon R, Forestier G, Bricout N, Benhassen W, Turc G, Bretzner M & al , Cerebral microbleeds and risk of symptomatic hemorrhagic transformation following mechanical thrombectomy for large vessel ischemic stroke., J Neurol, 2024
Gurol U, Scopelliti G, Cordonnier C, Puy L , Long-term headache after spontaneous intracerebral haemorrhage., Eur J Neurol, 2024 , e16247
Kreisler A, Watel K, Defebvre L, Mortain L, Duhamel A , Does the guidance method affect the doses of botulinum toxin in writer's cramp?, Rev Neurol (Paris), 2024
Barbosa RP, Moreau C, Rolland AS, Rascol O, Brefel-Courbon C, Ory-Magne F & al , The impact of subthalamic deep-brain stimulation in restoring motor symmetry in Parkinson's disease patients: a prospective study., J Neurol, 2024
Rochoy M, Pontais I, Caserio-Schönemann C, Chan-Chee C, Gainet L, Gobert Y & al , Pattern of encounters to emergency departments for suicidal attempts in France: Identification of high-risk days, months and holiday periods., Encephale, 2024
Rogeau A, Hives F, Bordier C, Lahousse H, Roca V, Lebouvier T & al , A 3D convolutional neural network to classify subjects as Alzheimer's disease, frontotemporal dementia or healthy controls using brain 18F-FDG PET., Neuroimage, 2024 , 120530
Damier P, Degos B, Castelonovo G, Anheim M, Benatru I, Carrière N & al , A Double-Blind, Randomized, Placebo-Controlled Trial of Bumetanide in Parkinson's Disease., Mov Disord, 2024
Nicolas G, Zaréa A, Lacour M, Quenez O, Rousseau S, Richard AC & al , Assessment of Mendelian and risk factor genes in Alzheimer disease: a prospective nationwide clinical utility study and recommendations for genetic screening., Genet Med, 2024 , 101082
Faggianelli F, Witjas T, Azulay JP, Benatru I, Hubsch C, Anheim M & al , ON/OFF non-motor evaluation: a new way to evaluate non-motor fluctuations in Parkinson's disease., J Neurol Neurosurg Psychiatry, 2024
Salort-Campana E, Solé G, Magot A, Tard C, Noury JB, Behin A & al , Multidisciplinary team meetings in treatment of spinal muscular atrophy adult patients: a real-life observatory for innovative treatments., Orphanet J Rare Dis, 2024 , 24
Mazighi M, Köhrmann M, Lemmens R, Lyrer PA, Molina CA, Richard S & al , Safety and efficacy of platelet glycoprotein VI inhibition in acute ischaemic stroke (ACTIMIS): a randomised, double-blind, placebo-controlled, phase 1b/2a trial., Lancet Neurol, 2024 , 157-167
Abdalkader M, Ning S, Qureshi MM, Haussen DC, Strbian D, Nagel S & al , Sex Differences in Outcomes of Late-Window Endovascular Stroke Therapy., Stroke, 2024 , 278-287
Pruvost R, Csanyi M, Lefebvre G, Biancalana V, Malfatti E, Cassim F & al , New mutations identified in a case of Glycogenin-1 deficiency., Mol Genet Metab Rep, 2024 , 101046
Benussi A, Premi E, Grassi M, Alberici A, Cantoni V, Gazzina S & al , Diagnostic accuracy of research criteria for prodromal frontotemporal dementia., Alzheimers Res Ther, 2024 , 10
Wirth T, Goetsch T, Corvol JC, Roze E, Mariani LL, Vidailhet M & al , Prognosis of impulse control disorders in Parkinson's disease: a prospective controlled study., J Neurol, 2024
Best JG, Ambler G, Wilson D, Du H, Lee KJ, Lim JS & al , Clinical Associations and Prognostic Value of MRI-Visible Perivascular Spaces in Patients With Ischemic Stroke or TIA., Neurology, 2024 , e207795
Sharma M, Molina CA, Toyoda K, Bereczki D, Bangdiwala SI, Kasner SE & al , Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial., Lancet Neurol, 2024 , 46-59
